Simplex Trading
ACET icon

Simplex Trading’s Adicet Bio ACET Stock Holding History

Simplex Trading’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.49K Buy
1,393
+1,306
+1,501% +$9.78K ﹤0.01% 7408
2025
Q4 		$732 Buy
+87
New +$962 ﹤0.01% 8096
2025
Q3 		– Sell
-36
Closed -$424 – 8930
2025
Q2 		$0 Sell
36
-80
-69% -$844 ﹤0.01% 8486
2025
Q1 		$1K Sell
116
-789
-87% -$11.3K ﹤0.01% 8126
2024
Q4 		$13K Buy
905
+504
+126% +$9.51K ﹤0.01% 6978
2024
Q3 		$9K Buy
+401
New +$8.98K ﹤0.01% 7222
2024
Q1 		– Sell
-1,034
Closed -$42.8K – 8712
2023
Q4 		$31K Buy
1,034
+100
+11% +$2.18K ﹤0.01% 6521
2023
Q3 		$20K Buy
934
+888
+1,930% +$31.4K ﹤0.01% 6602
2023
Q2 		$1K Sell
46
-136
-75% -$12K ﹤0.01% 8550
2023
Q1 		$16K Buy
+182
New +$22.8K ﹤0.01% 7108
2022
Q4 		– Sell
-966
Closed -$241K – 9058
2022
Q3 		$219K Buy
+966
New +$245K ﹤0.01% 4487
2022
Q2 		– Sell
-77
Closed -$16.9K – 9811
2022
Q1 		$24K Sell
77
-979
-93% -$225K ﹤0.01% 8014
2021
Q4 		$295K Buy
1,056
+981
+1,308% +$168K ﹤0.01% 4590
2021
Q3 		$11K Hold
75
– – ﹤0.01% 8855
2021
Q2 		$12K Buy
+75
New +$15.3K ﹤0.01% 8961
2020
Q3 		– Hold
0
– – – 7678
2020
Q2 		– Sell
-276
Closed -$54.2K – 7494
2020
Q1 		$31K Buy
276
+263
+2,023% +$39K ﹤0.01% 5580
2019
Q4 		$2K Buy
+13
New +$6.58K ﹤0.01% 6938

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Simplex Trading's ACET Position: Q1 2026 in Review

Simplex Trading increased its Adicet Bio (ACET) stake by 1,501% in Q1 2026, buying an estimated $9.78K and bringing the position to 1,393 shares worth $9.49K. The position accounts for ﹤0.01% of the portfolio, ranked #7408.

Simplex Trading first reported a position in ACET in Q4 2019 and has held it in 17 quarters since. The position peaked at $295K in Q4 2021. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Simplex Trading held 1,393 shares of Adicet Bio worth $9.49K as of Q1 2026.
  • Simplex Trading bought 1,306 Adicet Bio shares in Q1 2026, an estimated $9.78K.
  • Adicet Bio made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7408 holding.
  • Simplex Trading first reported a position in Adicet Bio in Q4 2019 and has held it in 17 quarters since.
  • Simplex Trading's Adicet Bio position peaked at $295K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.